SUGAR LAND, TX--(Marketwired - Jun 25, 2013) - Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- With 2013 almost half over, the Life Science sector is busy finishing out an impressive array of capital construction projects. As the second quarter enters its final days, the Life Science sector is on target to complete construction on a total of 69 North American capital projects, each as diverse as the industry itself. A recent survey of reported projects in Industrial Info's Pharmaceutical Tracker - Online Database reveals that the projects represent a total investment value (TIV) of $3.2 billion.
Companies featured: Gilead Sciences (NASDAQ:GILD), St. Jude Medical (NYSE:STJ)
For details, view the entire article by subscribing to Industrial Info's Premium Industry News at http://www.industrialinfo.com/news/abstract.j...6&refer=mw , or browse other breaking industrial news stories at www.industrialinfo.com .
Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, and eight offices outside of North America, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the www.industrialinfo.com " Contact Us " page.
Contact: Joe Govreau 713-783-5147
